HIV and AIDS Trial, Recruiting NCT06784154 Sponsor: University of Liverpool Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06784154
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 40 years old
  • You are HIV-positive
  • You have been on a stable HIV treatment (antiretroviral therapy) for more than 6 months, with two recent test results showing the virus is undetectable in your blood
  • Your immune cell count (CD4) has been at a healthy level (above 200 cells/mm³) for more than 2 years before joining the trial
  • You are able to understand what the study involves, follow the study procedures, and are willing to give written consent to take part

Who may not be able to join:

  • You are not able to follow the study procedures
  • You have a history of serious kidney problems (confirm with trial site)
  • You have a history of serious liver problems (confirm with trial site)
  • You currently have active hepatitis B or hepatitis C infection
  • You have any ongoing illness that the trial doctor feels would prevent you from safely taking part
  • You have a history of cancer
  • You are currently using illegal drugs through injection
  • Your screening test results show any other abnormal findings that the trial doctor considers relevant
  • You have previously used or are currently using a type of medication called a GLP-1 agonist (such as medications used for diabetes or weight loss — confirm with trial site)
  • You are pregnant or breastfeeding (for women only)
  • You are currently taking certain medications, including some antipsychotics, omega-3 supplements, certain blood pressure medications (Telmisartan or Irbesartan), certain diabetes medications (Thiazolidinediones), or regularly taking anti-inflammatory painkillers (NSAIDs)
  • You have an inherited condition that causes very high cholesterol levels (familial hypercholesterolaemia)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Liverpool
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
30 June 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Epicardial adipose tissue volume

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov